RESEARCH-USE BIOSIMILAR ANTIBODY

Plutavimab

Monoclonal antibody · IgG1 kappa

SARS-CoV-2 Spike RBDIgG1 kappaRUO

Plutavimab is a genetically human biosimilar reference antibody directed against SARS-CoV-2 Spike RBD.

TARGETSARS-CoV-2 Spike RBD
YMonoclonal antibody
CATALOGSC-BS-265
CATALOG NUMBERSC-BS-265
MOLECULAR WEIGHTApprox. 143.981 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Plutavimab is a genetically human biosimilar reference antibody directed against SARS-CoV-2 Spike RBD.

Plutavimab is a recombinant research-use antibody directed against SARS-CoV-2 Spike RBD.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Plutavimab | StellaCyte